Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Drug ineffective, Nasopharyngitis
Clinical narrative: the COVID that he had was causing this; the COVID that he had was causing this; Pretty bad chills/had a heating pad on him and he was still cold; Pretty bad chills/had a heating pad on him and he was still cold; This is a spontaneous report received from a Consumer or other non HCP, Program ID:  A 66-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Sep2024 as dose 1, single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation. The patient's relevant medical history included: "SLL, non-Hodgkin lymphoma", start date: 2022 (ongoing), notes: diagnosed in the spring of 2022, during a routine physical; "COVID" (unspecified if ongoing), notes: once in 2020, in late Feb2020; "B12 level was low" (unspecified if ongoing), notes: had four consecutive B12 injections a week apart and he took B12, 1000 micrograms everyday at night. The patient's family history included: "COVID" (unspecified if ongoing), notes: The patient's family member passed from COVID. Concomitant medication(s) included: VARICELLA ZOSTER VACCINE taken for immunisation as dose 2, single; INFLUENZA VACCINE taken for immunisation as dose number unknown, single; PNEUMOCOCCAL VACCINE taken for immunisation as dose number unknown, single; VENETOCLAX taken for b-cell small lymphocytic lymphoma; ZANUBRUTINIB taken for b-cell small lymphocytic lymphoma. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Batch/lot number: EN6198), administration date: 18Feb2021, when the patient was 61-year-old, for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for Covid-19 immunization; Bnt162b2;bnt162b2 omi ba.4-5 (DOSE 4 (BOOSTER), SINGLE), for Covid-19 immunization; Comirnaty (2023-2024 formula) (DOSE 5 (BOOSTER), SINGLE), for Covid-19 immunization; Shingles shot (Dose 1, manufacturer unknown), for immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "the COVID that he had was causing this"; CHILLS (non-serious), NASOPHARYNGITIS (non-serious), outcome "not recovered" and all described as "Pretty bad chills/had a heating pad on him and he was still cold". Therapeutic measures were taken as a result of drug ineffective, covid-19, chills, nasopharyngitis. Clinical course: The patient had had six Pfizer COVID vaccines, the last one in Sep of last year (Sep2024). The patient also took the second shingles shot, flu shot and pneumonia shot, all four of them (included covid shot), two weeks apart over the course of a month. The patient took care of himself and did not know how he got this. When he thought though which do not know was that he was immunocompromised because of his cancer diagnosis and chemo drugs that he was on, so his platelet count was low and that might had exacerbated what was going on, the cancer was diagnosed in 2022, the doctor saw a swelling in his neck, it looked like a goiter and he went for all kind of tests and this was what it was. He was taking two chemo drugs or the non-chemo drugs, called as co-targeted therapy, that was for the cancer. He was not allowed to take the drugs while he was on this protocol though, once he took this medication for 5 days, he would not be allowed to take his chemo drugs, he was going to be off it for five days. The patient had lab work in the hospital this morning (10Jun2025). He want to ask that if the COVID that he had was causing this or could it be something else. He had been suffering from chills, from pretty bad chills. He was lying in bed right now. He had a heating pad on me and he was still cold. He felt it was like somebody put an ice cube on top of him. H e did not get it. He wondered if chills were part of COVID protocol.  The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500119149 same patient/drug, different dose/event;